Health Canada (HC) (11) · House of Commons (3) · Innovation, Science and Economic Development Canada (ISED) (3) · Privy Council Office (PCO) (2) · Finance Canada (FIN) (1)
In their own words
In terms of science and technology, we work toward the development of precision and personalized medicines that target the basic defect of cystic fibrosis. We are exploring how the federal government may support these efforts through partnership and funding.
Improving access to precision medicines for Canadians with cystic fibrosis and other rare diseases.
Meetings from the Commissioner of Lobbying of Canada. Canada does not require lobbyists to disclose what they spend, so there is no lobbying budget to report here — only the meetings they filed.